The analysis of second-trimester triple screening for Down syndrome in Chinese normal singleton pregnancies

被引:9
|
作者
Wan, Xiaohua [1 ]
Wen, Jiangping [1 ]
Song, Xin [1 ]
Guo, Yongjun [1 ]
Liu, Xiangyi [1 ]
Yang, Benshan [1 ]
Lu, Xinxin [1 ]
机构
[1] Capital Med Univ, Beijing Tongren Hosp, Dept Clin Lab, Beijing 100730, Peoples R China
关键词
Second-trimester; triple screening; Down syndrome; alpha fetoprotein; human chorionic gonadotropin; unconjugated estriol; HUMAN CHORIONIC-GONADOTROPIN; SERUM ALPHA-FETOPROTEIN; MATERNAL SERUM; TECHNICAL STANDARDS; WEIGHT-CORRECTION; GUIDELINES; ANALYZER; MEDIANS; MARKERS;
D O I
10.3109/00365513.2012.729858
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background and objectives. The study aimed to compare the a fetoprotein (AFP), total beta-human chorionic gonadotropin (hCG), and unconjugated estriol (uE3) levels in the second-trimester triple screening for Down syndrome with different regions, and to analyse the related factors that influenced the screening performance. Materials and methods. The study was conducted between February 2007 and November 2010 in Beijing Tongren Hospital, P. R. China. Data derived from 7,647 normal singleton pregnancies between 14 and 21 weeks of gestation were examined. The regressed median values in different gestational ages were compared with earlier published data from other regions. The distribution of median values and multiples of median (MoM) of AFP, hCG and uE3 according to maternal age and weight in normal pregnancies were described. Statistic parameters for AFP, hCG, and uE3 (based on log(10) MoM values) were compared with earlier published data from other studies. Results. There were significantly increasing trends for AFP (p < 0.001) and uE3 (p < 0.001), and a significantly decreasing trend for hCG (p < 0.001) in the second trimester. There were significantly decreasing trends with increasing maternal weight for all the markers and their MoMs (p < 0.001). The distribution of the log(10) MoM marker values were Gaussian for the three parameters. Conclusions. Ethnic and laboratory variance should be taken into account in the second trimester triple screening for Down syndrome. The parameters of maternal serum markers should be calculated using local data, and the algorithm modified to match the screening achievable for the local population.
引用
收藏
页码:642 / 647
页数:6
相关论文
共 50 条
  • [21] Accuracy of expected risk of Down syndrome using the second-trimester triple test
    Meier, C
    Huang, TH
    Wyatt, PR
    Summers, AM
    CLINICAL CHEMISTRY, 2002, 48 (04) : 653 - 655
  • [22] First-trimester screening for Down syndrome in singleton pregnancies achieved by intrauterine insemination
    Lai, TH
    Chen, SC
    Tsai, MS
    Lee, FK
    Wei, CF
    JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 2003, 20 (08) : 327 - 331
  • [23] First-Trimester Screening for Down Syndrome in Singleton Pregnancies Achieved by Intrauterine Insemination
    Tsung-Hsuan Lai
    Su-Chee Chen
    Ming-Song Tsai
    Fa-Kung Lee
    Chi-Feng Wei
    Journal of Assisted Reproduction and Genetics, 2003, 20 : 327 - 331
  • [24] Agreement between predicted risk and prevalence of Down syndrome in second-trimester triple-marker screening in Japan
    Onda, T
    Tanaka, T
    Takeda, O
    Kitagawa, M
    Kuwabara, Y
    Yamamoto, H
    Iinuma, K
    Shimomura, K
    PRENATAL DIAGNOSIS, 1998, 18 (09) : 956 - 958
  • [25] ADAM 12 as a second-trimester maternal serum marker in screening for Down syndrome
    Christiansen, Michael
    Spencer, Kevin
    Laigaard, Jennie
    Cowans, Nicholas J.
    Larsen, Severin Olesen
    Wewer, Ulla M.
    PRENATAL DIAGNOSIS, 2007, 27 (07) : 611 - 615
  • [27] How to combine first- and second-trimester Down syndrome screening tests
    Benn, P
    Egan, J
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2003, 189 (06) : S112 - S112
  • [28] First trimester biochemical screening for Down's syndrome in singleton pregnancies conceived by assisted reproduction
    Bellver, J
    Lara, C
    Soares, SR
    Ramírez, A
    Pellicer, A
    Remohí, J
    Serra, V
    HUMAN REPRODUCTION, 2005, 20 (09) : 2623 - 2627
  • [29] Clinical first-trimester routine screening for Down syndrome in singleton pregnancies in northern Finland
    Valinen, Yrtti
    Rapakko, Katrin
    Kokkonen, Hannaleena
    Laitinen, Paivi
    Tekay, Aydin
    Ahola, Tarja
    Ryynanen, Markku
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2007, 196 (03) : 278 - 279
  • [30] Second-trimester maternal serum screening for Down syndrome in twin-to-twin transfusion syndrome
    Sermondade, Nathalie
    Dreux, Sophie
    Oury, Jean-Francois
    Muller, Francoise
    PRENATAL DIAGNOSIS, 2009, 29 (08) : 814 - 815